📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.75
SENTIMENT
BULLISH
TOTAL VIEWS
3
RECENT COVERAGE · 3 ARTICLES
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Data in Ulcerative Colitis - Slideshow (NASDAQ:ABVX) 2026-07-01
ABIVAX disclosed updated clinical data for obefazimod, its investigational immunomodulator candidate, focusing on maintenance efficacy...
Abivax: Latest Obefazimod Data Eases Safety Fears, Brings M&A Back Into Play (NASDAQ:ABVX)
Abivax announced positive Phase 3 clinical trial results for obefazimod in ulcerative colitis (UC), demonstrating an improved safety...
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Data in Ulcerative Colitis Transcript
ABIVAX disclosed updated clinical data on obefazimod, its investigational immunomodulator candidate for ulcerative colitis, focusing on...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice